Oncology Institute Stock
The Oncology Institute, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Country
- United States
- CEO
- Daniel Virnich
- Employees
- 641
- Market cap
- $513 M
- IPO
- 04/06/2020
The Oncology Institute (TOI) is a specialized healthcare provider delivering a full range of medical oncology services throughout the United States. Its comprehensive offerings include direct physician care, integrated on-site infusion and medication dispensing facilities, and advanced clinical trial management. The…
Oncology Institute stock: price history
1D
+0.8%
1W
+4.4%
1M
-2.1%
6M
+89.4%
YTD
+45.2%
1Y
+28.3%
2Y
+859.4%
5Y
-47.8%
10Y
–
Next earnings date
Next earnings date
No date known
Volatility around earnings
~58% stronger price swings than usual
Ask the agents about Oncology Institute
Analyst assessment of Oncology Institute
PRICE TARGET LOW
US$7.00
CONSENSUS
US$8.67
MEDIAN
US$9.00
PRICE TARGET HIGH
US$10.00
0
STRONG BUY
5
BUY
0
HOLD
0
SELL
0
STRONG SELL
5
TOTAL · Buy
As of: 09/07/2026
Oncology Institute stock metrics
P/E
-18.32
P/B
-21.22
EV/EBITDA
-22.71
RETURN ON EQUITY
39.3%
NET MARGIN
-6.1%
DEBT/EQUITY
-0.99
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
49.4%
FLOAT SHARES
49,401,265
AVG. DAILY VOLUME (30D)
1,929,466
Insider transactions (SEC)
Chernett Jorey
Kaushal Mohit
McGeorge Anne
Pacala Mark L
STOLPER MARK
Institutional holders
Comparable stocks
Frequently asked questions about Oncology Institute stock
What does Oncology Institute do?
The Oncology Institute, Inc. is a company in the Healthcare sector, Medical - Care Facilities industry, headquartered in United States.
The CEO is Daniel Virnich, the company employs around 641 people.
The IPO was on 04/06/2020; the stock trades on NASDAQ under the ticker TOI.
What do analysts say about Oncology Institute stock?
5 analysts rate the stock, the consensus is Buy (as of 09/07/2026).
The average price target is US$8.67, ranging from US$7.00 to US$10.00, with a median of US$9.00.
This is an external assessment, not a statement by Market Jury.
When does Oncology Institute report next?
Around past earnings, price swings were roughly 58% stronger than usual.
Does Oncology Institute pay a dividend?
No, Oncology Institute currently does not pay a dividend.
Which stocks are comparable to Oncology Institute?
Comparable stocks include HCA Healthcare, Tenet Healthcare, DaVita, Universal Health Services, Hims & Hers Health, LifeStance Health Group, Concentra Group Holdings Parent and Acadia Healthcare Company.
How can I get Oncology Institute stock analyzed?
Clicking "Analyze stock" lets five strategies assess Oncology Institute against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.